Timing of initiation of uremia therapy and survival in patients with progressive renal disease

American Journal of Nephrology

Volumn 18, Issue 3, 1998, Pages 193-198

  Ifudu, Onyekachi ^a   Dawood, Mohammed ^a   Homel, Peter ^a   Friedman, Eli A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Creatinine; Hemodialysis; Initiation; Survival; Uremia

Indexed keywords

CREATININE; NITROGEN; SERUM ALBUMIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD LEVEL; CAUCASIAN; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERKALEMIA; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE WEAKNESS; NAUSEA; NEGRO; PERICARDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; REGRESSION ANALYSIS; SEIZURE; SURVIVAL; TREATMENT INDICATION; UREA NITROGEN BLOOD LEVEL; UREMIA; VOMITING;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; UREMIA;

EID: 0031901096     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013336     Document Type: Article

References (15)

1. Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28:830-838.
2. Levy AS: Measurement of renal function in chronic renal disease. Kidney Int 1990;38:167-184.
3. Wish JB, Webb RL, Levin AS, Port FK, Held PJ: Medical appropriateness of initiating chronic dialysis in the US: Results of the revised medical evidence report pilot study (abstract). J Am Soc Nephrol 1994;5:345.
4. King AJ, Levey AS: Dietary protein and renal function. J Am Soc Nephrol 1993;3:1723-1737.
5. Cox DR: Regression models and life-tables. J R Stat Soc [B] 1972;34:187-202.
6. Norusis MJ: SPSS (Statistical Package for the Social Sciences) for Windows Advanced Statistics, Release 6.0. Chicago, SPSS, 1993, pp 1-30.
7. Ifudu O, Dawood M, Homel P, Friedman EA: Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996;28:841-845.
8. Tattersall JE, Greenwood RN, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 1995;15:283-289.
9. Bonomini V, Bladrati L, Stcfoni S: Comparative cost/benefit analysis in early and late dialysis. Nephron 1983;33:1-4.
10. Bonomini V, Feletti C, Scolari MP, Stefoni S: Benefits of early initiation of dialysis. Kidney Int 1985;28(suppl 17):57-59.
11. Solo Statistical System: Power Analysis. 1991 BMDP. Los Angeles, Statistical Software, Inc. 1991.
12. Morbidity and Mortality of Renal Dialysis: An NIH Consensus Conference Statement. Consensus Development Conference Panel. Ann Intern Med 1994;121:62-70.
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-192.
14. Striker G: Report on a workshop to develop management recommendations for the prevention of progression in chronic renal failure. J Am Soc Nephrol 1995;5:1537-1540.
15. US Department of Health and Human Services. Health Care Financing Administration: End-stage renal disease medical evidence report: Medicare entitlement/or patient registration. HCFA-2728-U4(4-95).